Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta‐analysis
Authors:
- 11 February 2013
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 120 (6) , 681-694
Abstract
Background: Several biomarkers for predicting intrauterine growth restriction (IUGR) have been proposed in recent years. However, the predictive performance of these biomarkers has not been systematically evaluated.Objective: To determine the predictive accuracy of novel biomarkers for IUGR in women with singleton gestations.Search strategy: Electronic databases, reference list checking and conference proceedings.Selection criteria: Observational studies that evaluated the accuracy of novel biomarkers proposed for predicting IUGR.Data collection and analysis: Data were extracted on characteristics, quality and predictive accuracy from each study to construct 2 × 2 tables. Summary receiver operating characteristic curves, sensitivities, specificities and likelihood ratios (LRs) were generated.Main results: A total of 53 studies, including 39 974 women and evaluating 37 novel biomarkers, fulfilled the inclusion criteria. Overall, the predictive accuracy of angiogenic factors for IUGR was minimal (median pooled positive and negative LRs of 1.7, range 1.0–19.8; and 0.8, range 0.0–1.0, respectively). Two small case–control studies reported high predictive values for placental growth factor and angiopoietin‐2 only when IUGR was defined as birthweight centile with clinical or pathological evidence of fetal growth restriction. Biomarkers related to endothelial function/oxidative stress, placental protein/hormone, and others such as serum levels of vitamin D, urinary albumin : creatinine ratio, thyroid function tests and metabolomic profile had low predictive accuracy.Conclusions: None of the novel biomarkers evaluated in this review are sufficiently accurate to recommend their use as predictors of IUGR in routine clinical practice. However, the use of biomarkers in combination with biophysical parameters and maternal characteristics could be more useful and merits further research.Keywords
This publication has 87 references indexed in Scilit:
- PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy ComplicationsPLOS ONE, 2011
- Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Low maternal PAPP‐A is associated with small‐for‐gestational age newborns and stillbirthsActa Obstetricia et Gynecologica Scandinavica, 2010
- Defining normal and abnormal fetal growth: promises and challengesAmerican Journal of Obstetrics and Gynecology, 2010
- Maternal Serum 25-Hydroxyvitamin D Concentrations Are Associated with Small-for-Gestational Age Births in White WomenThe Journal of Nutrition, 2010
- Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysisBMC Pregnancy and Childbirth, 2008
- The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational ageThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infantsAmerican Journal of Obstetrics and Gynecology, 2008
- Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factorAmerican Journal of Obstetrics and Gynecology, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002